SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort

Table 4 The COVID-19 disease course of the patients’ cohabitants

	Relationship	Age (y)	Injected doses of SARS-CoV-2 vaccine	COVID-19 severance†	Onset date compared with the patient (day)‡	Presentation	RT-PCR positive duration (days)	Duration compared with the patient (day) §	Treatment	Relapse
Patient A	mother	32	2	Mild	−7	fever	10	−30	None	None
Patient A	Father	36	2	Mild	0	fever	10	−30	None	None
Patient B	Grandmother	52	3	Mild	−2	fever for 2 days	20	−9	None	None
Patient B	Mother	28	2	Mild	−1	fever for 2 days	19	−10	None	None
Patient C	Mother	38	1	Uninfected	-	-	0	-	Antipyretic	None
Patient D	Mother	35	2	Mild	−3	fever, myalgia, sore throat for 2 days	14	−5	None	None
Patient D	Aunt	49	2	Mild	0	sore throat for 1 day	21	2	None	None
Patient E	Father	28	3	Mild	1	dry cough for > 11 days	5	−13	None	None
Patient E	Mother	30	0	Mild	-3	dry cough, fatigue for > 13 days	3	−15	None	None

†The uninfected is defined as cases with no positive results in RT-qPCR. The mild is defined as cases with upper respiratory tract symptoms and normal respiratory system examination. The moderate is defined as cases with abnormal radiological findings as pneumonia without the symptoms of dyspnea and hypoxemia
‡Onset date compared with the patient is defined as the onset date of the co-habitant minus that of the patient. A negative number means the infection of the co-habitant starts earlier than the patient, while 0 means the infection starts on the same day
§Duration compared with the patient is defined as the infection duration of the co-habitant minus that of the patient. A negative number means the infection duration of the co-habitant is shorter than that of the patient, while a positive number means the infection duration is longer than that of the patient
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Corona Virus Disease 2019, RT-qPCR real-time reverse transcriptase polymerase chain reaction assay

ISSN: 1743-422X